Vytrus Biotech: Funding, Investors & Team (Sep 2026)
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded by scientists from the Plant Biotechnology research group in 2009. The company leverages the expertise gained by this group over three decades to develop products and solutions for the commercial market. Specializing in Plant Biotechnology, Phyture Biotech produces valuable active ingredients and recombinant proteins for the cosmetics and pharmaceutical industries. In 2016, the company rebranded as Vytrus Biotech.
Vytrus Biotech has raised $4.8M across 2 funding rounds on record, the most recent an undisclosed round of $2.3M announced in Jan 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vytrus Biotech Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Vytrus Biotech Funding Rounds
Vytrus Biotech raised $2.5M in an undisclosed round announced in May 2024.
1.7 years later, an undisclosed round of $2.3M was announced in Jan 2026.
Vytrus Biotech Founders and Leadership Team
Contact details for the Vytrus Biotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Vytrus Biotech Funding Compared to Other Biotechnology Startups
Vytrus Biotech's latest round of $2.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vytrus Biotech in Biotechnology and Barcelona
Companies Similar to Vytrus Biotech
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of…
Vytrus Biotech Funding FAQs
What does Vytrus Biotech do?
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded by scientists from the Plant Biotechnology research group in 2009. The company leverages the expertise gained by this group over three decades to develop products and solutions for the commercial market. Specializing in Plant Biotechnology, Phyture Biotech produces valuable active ingredients and recombinant proteins for the cosmetics and pharmaceutical industries. In 2016, the company rebranded as Vytrus Biotech.
How much funding has Vytrus Biotech raised?
Vytrus Biotech has raised $4.8M across 2 rounds on record. The most recent is an undisclosed round of $2.3M announced in Jan 2026.
When did Vytrus Biotech last raise funding?
Vytrus Biotech's most recent funding round on record is an undisclosed round of $2.3M, announced in Jan 2026.
Who founded Vytrus Biotech?
FundedIQ lists Oscar Exposito Tarres (Founder) at Vytrus Biotech.
Where is Vytrus Biotech headquartered?
Vytrus Biotech is based in Barcelona, Catalonia, Spain.
How many employees does Vytrus Biotech have?
Vytrus Biotech is in the 11-50 employee band.
How does Vytrus Biotech's funding compare to other Biotechnology startups?
Vytrus Biotech's latest round of $2.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Vytrus Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vytrus Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.